-
-
-
WE NEVER STOP
Discovering New Treatments. Delivering Better Outcomes. Providing Personalized Care. Focusing on You.
-
-
-
Check Out Fox Chase’s New Annual Report
-
This Clinical Study About Myelofibrosis Treatment Could Transform Patient Care
World-class clinicians and researchers like Peter Abdelmessieh, Department of Bone Marrow Transplant and Cellular Therapies at Fox Chase Cancer Center, and Tomaz Skorski, MD, PhD, Dsc, Lewis Katz School of Medicine at Temple University, are driving the mission to improve survival rates for myelofibrosis patients with a promising clinical study, based on their discovery of the role of PARP inhibitors and myelofibrotic cell death.
Fox Chase Cancer Center is proud to be an integral part of Temple Health. Along with offering our patients the best in cancer care, we also provide unparalleled access to a vast network of physicians, specialty clinical care for a variety of other healthcare needs, and groundbreaking clinical trials and treatments.